Description

3-[(3-Methoxybenzoyl)Amino]-4-(4-Methyl-1-Piperazinyl)Benzoic Acid Methyl Ester is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound matters for its critical role in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in research and development pipelines targeting specific therapeutic areas. It is primarily needed by pharmaceutical R&D laboratories, fine chemical manufacturers, and contract research organizations (CROs) engaged in developing new drug candidates.

Application

• Pharmaceutical Intermediate: Key building block in the research and synthesis of novel drug candidates, particularly in medicinal chemistry programs.
• Chemical Synthesis: Used as a specialized precursor for constructing complex molecules with piperazine and benzoate moieties in organic chemistry.
• Research & Development: Serves as a reference standard or starting material in academic and industrial R&D for pharmacological studies.
• API Development: Integral component in the development pathway for new Active Pharmaceutical Ingredients (APIs), requiring high chemical purity.
• Fine Chemical Production: Employed in the multi-step synthesis of high-value, low-volume specialty chemicals for advanced applications.

Basic Information

Product Name	3-[(3-Methoxybenzoyl)Amino]-4-(4-Methyl-1-Piperazinyl)Benzoic Acid Methyl Ester
CAS No.	890190-22-4
Molecular Formula	C21H25N3O4
Molecular Weight	383.44 g/mol
Synonyms	Methyl 3-[(3-methoxybenzoyl)amino]-4-(4-methylpiperazin-1-yl)benzoate; 4-(4-Methyl-1-piperazinyl)-3-[(3-methoxybenzoyl)amino]benzoic Acid Methyl Ester; 890190-22-4; Benzoic acid, 3-[(3-methoxybenzoyl)amino]-4-(4-methyl-1-piperazinyl)-, methyl ester; Methyl 3-(3-methoxybenzamido)-4-(4-methylpiperazin-1-yl)benzoate
EINECS	Contact for details

Quality Control

Our 3-[(3-Methoxybenzoyl)Amino]-4-(4-Methyl-1-Piperazinyl)Benzoic Acid Methyl Ester is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment to guarantee traceability and consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed in a dry environment to prevent degradation. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.